Advertisement
Screener

BIONIK LABORATORIES CORP. Income (Loss) from Continuing Operations, Per Basic and Diluted Share

BIONIK LABORATORIES CORP. Income (Loss) from Continuing Operations, Per Basic and Diluted Share

BIONIK LABORATORIES CORP. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-15.

Discontinued › Income Statement › Other Income

us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2012-05-15

  • BIONIK LABORATORIES CORP. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2012-03-31 was $0.00.
  • BIONIK LABORATORIES CORP. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2011-03-31 was $0.00.
Period endIncome (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month
2012-03-31$0.00
10-Q · filed 2012-05-15
2011-03-31$0.00
10-Q · filed 2012-05-15